FDA panel votes unanimously in favor of Merck & Co's Sugammadex

Nov 6 (Reuters) - Merck & Co's drug to reverse the effects of muscle relaxants used in surgery is safe and effective enough to warrant approval, an independent panel to the U.S. Food and Drug...